Lihe Su
8Patents
3h-index
16Co-inventors
50Inventor score
Filing activity: Nov 17, 2006 → Mar 7, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8784823B2 | Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof | Chemistry; Metallurgy | 25 | Active |
| US8293237B2 | Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof | Chemistry; Metallurgy | 24 | Active |
| US9580493B2 | Anti-α synuclein binding molecules | Physics | 8 | Active |
| US10301381B2 | Anti-alpha synuclein binding molecules | Physics | 2 | Active |
| US9975947B2 | Anti-alpha synuclein binding molecules | Physics | 2 | Active |
| US9321840B2 | Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US9297810B2 | CD40L-binding agent based platelet aggregation assays | Physics | 0 | Active |
| US8409810B2 | Platelet aggregation assays using a CD40L-binding agent | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.